Ertapenem rescue therapy in hidradenitis suppurativa

Hidradenitis suppurativa (HS) is a chronic, inflammatory, follicular disorder which presents with significant treatment challenges, largely in part because the pathogenesis is not well understood. While there are many new and emerging therapies, HS flares often remain difficult to control, and concerns of infection throughout the disease course remain prominent. Ertapenem use in HS represents a novel therapy. A recent study found significant improvement in pain and drainage of HS lesions following six weeks of daily intravenous (IV) infusion through a peripherally inserted central catheter.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research